Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 19, 2019 - Issue 11
Submit an article Journal homepage
1,895
Views
6
CrossRef citations to date
0
Altmetric
Special Report

Genomic testing in healthcare: a hybrid space where clinical practice and research need to co-exist

Rachel HortonClinical Ethics and Law at Southampton (CELS), Faculty of Medicine, University of Southampton, UK;Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UKORCID Iconhttps://orcid.org/0000-0001-6080-6354View further author information
ORCID Icon &
Anneke LucassenClinical Ethics and Law at Southampton (CELS), Faculty of Medicine, University of Southampton, UK;Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3324-4338View further author information
ORCID Icon
Pages 963-967 | Received 29 Jul 2019, Accepted 23 Sep 2019, Published online: 11 Oct 2019

References

  • Dheensa S, Samuel G, Lucassen AM, et al. Towards a national genomics medicine service: the challenges facing clinical-research hybrid practices and the case of the 100 000 genomes project. J Med Ethics. 2018;44(6):397–403.
  • Beauchamp TL. The Idea of a “Standard View” of Informed Consent. Am J Bioeth. 2017;17(12):1–2.
  • Yong J, Moffett M, Lucas S. Implementing a global expanded access program (EAP) for infantile-onset spinal muscular atrophy (type I): understanding the imperative, impact and challenges. J Neuromuscul Dis. 2019;6(2):227–231.
  • NICE. Nusinersen for treating spinal muscular atrophy: appraisal consultation document. [cited 2019 Sep 3]. Available from: https://www.nice.org.uk/guidance/ta588/documents/appraisal-consultation-document2018.
  • NICE. Nusinersen for treating spinal muscular atrophy: technology appraisal guidance [TA588]. [citec 2019 Sep 3]. Available from: https://www.nice.org.uk/guidance/ta5882019.
  • Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19(5):253–268.
  • Rosenthal ET, Bowles KR, Pruss D, et al. Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes. Clin Genet. 2015;88(6):533–541.
  • Horton R, Lucassen A, Fenwick A. Unpacking the concept of a genomic result. Am J Bioeth. 2019;19(1):70–71.
  • Horton R, Lucassen A. Consent and autonomy in the genomics Era. Current Genet Med Rep. 2019;7(2):85–91.
  • Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–424.
  • Wright CaW JS, Lucassen AM, Hall A, et al. Genomic variant sharing: a position statement [version 1; referees: awaiting peer review]. Wellcome Open Res. 2019;4:22.
  • Wright CF, West B, Tuke M, et al. Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting. Am J Hum Genet. 2019;104(2):275–286.
  • Firth HV, Wright CF, Study D. The deciphering developmental disorders (DDD) study. Dev Med Child Neurol. 2011;53(8):702–703.
  • Caulfield M, Davies J, Dennys M, et al. The 100,000 Genomes Project Protocol. 2015.
  • Wright CF, McRae JF, Clayton S, et al. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet Med. 2018;20(10):1216-1223.
  • Horton RH, Lucassen AM. Recent developments in genetic/genomic medicine. Clin Sci (Lond). 2019;133(5):697–708.
  • Faden RR, Kass NE, Goodman SN, et al. An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. Hastings Cent Rep. 2013;43(S1):S16–27.
  • Mullins CD, Wingate LMT, Edwards HA, et al. Transitioning from learning healthcare systems to learning health care communities. J Comp Eff Res. 2018;7(6):603–614.
  • Sethi, N. Regulating for uncertainty: bridging blurred boundaries in medical innovation, research and treatment. Law Innovation Technol. 2019;11(1):112–133.
  • Bertier G, Cambon-Thomsen A, Joly Y. Is it research or is it clinical? Revisiting an old frontier through the lens of next-generation sequencing technologies. Eur J Med Genet. 2018;61(10):634–641.
  • Davies S Annual Report of the Chief Medical Officer 2016, Generation Genome. 2017.
  • Fenwick A, Shkedi-Rafid S, Lucassen A. Relative risk and relatives’ risks in genomic medicine. Am J Bioeth. 2016;16(2):25–27.
  • Reijnders MRF, Janowski R, Alvi M, et al. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature. J Med Genet. 2018;55(2):104–113.
  • Hunt D, Leventer RJ, Simons C, et al. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability. J Med Genet. 2014;51(12):806–813.
  • Kass NE, Faden RR. Ethics and learning health care: the essential roles of engagement, transparency, and accountability. Learn Health Syst. 2018;2(4):e10066.
  • Fletcher I, Birko S, Dove ES, et al. Co-production and managing uncertainty in health research regulation: a Delphi study. Health Care Anal. 2019 [Epub ahead of print]. doi: 10.1007/s10728-019-00383-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.